Mathes Company’s Merck MRK Stock Holding History

Mathes Company’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$591K	Sell	4,915 -10	-0.2%	-$1.15K	0.22%	75
2025 Q4	$518K	Hold	4,925	–	–	0.18%	81
2025 Q3	$413K	Hold	4,925	–	–	0.15%	94
2025 Q2	$390K	Sell	4,925 -50	-1%	-$3.97K	0.14%	95
2025 Q1	$447K	Sell	4,975 -550	-10%	-$51.4K	0.18%	86
2024 Q4	$550K	Hold	5,525	–	–	0.2%	84
2024 Q3	$627K	Sell	5,525 -25	-0.5%	-$2.97K	0.22%	80
2024 Q2	$687K	Sell	5,550 -1,000	-15%	-$129K	0.25%	73
2024 Q1	$864K	Hold	6,550	–	–	0.32%	67
2023 Q4	$714K	Hold	6,550	–	–	0.29%	72
2023 Q3	$674K	Hold	6,550	–	–	0.31%	71
2023 Q2	$756K	Buy	+6,550	New	+$744K	0.33%	67
2022 Q4	$898K	Hold	8,094	–	–	0.45%	58
2022 Q3	$697K	Hold	8,094	–	–	0.39%	69
2022 Q2	$738K	Sell	8,094 -123	-1%	-$10.9K	0.36%	75
2022 Q1	$674K	Hold	8,217	–	–	0.26%	82
2021 Q4	$630K	Sell	8,217 -1,238	-13%	-$98.6K	0.22%	84
2021 Q3	$710K	Hold	9,455	–	–	0.26%	79
2021 Q2	$735K	Sell	9,455 -1,397	-13%	-$104K	0.26%	77
2021 Q1	$798K	Hold	10,852	–	–	0.31%	76
2020 Q4	$847K	Sell	10,852 -157	-1%	-$12K	0.34%	72
2020 Q3	$871K	Hold	11,009	–	–	0.41%	66
2020 Q2	$812K	Sell	11,009 -1,048	-9%	-$78.9K	0.4%	65
2020 Q1	$885K	Sell	12,057 -63	-0.5%	-$4.95K	0.59%	49
2019 Q4	$1.05M	Sell	12,120 -1,171	-9%	-$96.2K	0.49%	59
2019 Q3	$1.07M	Hold	13,291	–	–	0.55%	55
2019 Q2	$1.06M	Sell	13,291 -3,390	-20%	-$260K	0.56%	54
2019 Q1	$1.32M	Sell	16,681 -6,340	-28%	-$474K	0.67%	50
2018 Q4	$1.68M	Hold	23,021	–	–	1.06%	37
2018 Q3	$1.56M	Sell	23,021 -351	-2%	-$22.4K	0.73%	44
2018 Q2	$1.35M	Buy	23,372 +209	+0.9%	+$11.8K	0.65%	49
2018 Q1	$1.2M	Buy	23,163 +3,490	+18%	+$188K	0.56%	52
2017 Q4	$1.06M	Sell	19,673 -1,991	-9%	-$110K	0.48%	54
2017 Q3	$1.32M	Sell	21,664 -2,375	-10%	-$144K	0.62%	50
2017 Q2	$1.47M	Sell	24,039 -79	-0.3%	-$4.81K	0.7%	43
2017 Q1	$1.46M	Sell	24,118 -272	-1%	-$16.5K	0.78%	41
2016 Q4	$1.37M	Sell	24,390 -2,463	-9%	-$144K	0.75%	42
2016 Q3	$1.6M	Sell	26,853 -996	-4%	-$58.2K	0.91%	38
2016 Q2	$1.53M	Sell	27,849 -921	-3%	-$49K	0.89%	38
2016 Q1	$1.45M	Sell	28,770 -980	-3%	-$48K	0.87%	37
2015 Q4	$1.5M	Sell	29,750 -340	-1%	-$17.1K	0.85%	41
2015 Q3	$1.42M	Buy	30,090 +629	+2%	+$33.4K	0.94%	37
2015 Q2	$1.6M	Sell	29,461 -315	-1%	-$17.7K	0.85%	39
2015 Q1	$1.63M	Sell	29,776 -419	-1%	-$23.7K	0.84%	40
2014 Q4	$1.64M	Sell	30,195 -189	-0.6%	-$10.5K	0.86%	36
2014 Q3	$1.72M	Sell	30,384 -733	-2%	-$41.2K	0.87%	42
2014 Q2	$1.72M	Sell	31,117 -288	-0.9%	-$15.7K	0.85%	42
2014 Q1	$1.7M	Buy	31,405 +6	+0%	+$311	0.91%	38
2013 Q4	$1.5M	Buy	+31,399	New	+$1.44M	0.81%	42

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mathes Company's MRK Position: Q1 2026 in Review

Mathes Company reduced its Merck (MRK) stake by 0.2% in Q1 2026, selling an estimated $1.15K and leaving 4,915 shares worth $591K. The position accounts for 0.22% of the portfolio, ranked #75.

Mathes Company first reported a position in MRK in Q4 2013 and has held it in 49 quarters since. The position peaked at $1.72M in Q3 2014. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Mathes Company held 4,915 shares of Merck worth $591K as of Q1 2026.
Mathes Company sold 10 Merck shares in Q1 2026, an estimated $1.15K.
Merck made up 0.22% of Mathes Company's portfolio in Q1 2026, its #75 holding.
Mathes Company first reported a position in Merck in Q4 2013 and has held it in 49 quarters since.
Mathes Company's Merck position peaked at $1.72M in Q3 2014.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Mathes Company's 13F filing for Q1 2026, filed 8 May 2026.